News

You are a bioentrepreneur seeking new challenges or you are looking for a passionate CEO to lead your project?

You are a bioentrepreneur seeking new challenges or you are looking for a passionate CEO to lead your project?

If so, the Project – CEO matchmaking is made for you!

As talented CEOs are frequently sought-after by many players in the biotech industry, the Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators, and investing networks with CEOs and aspiring CEOs.

 Find the perfect match:
• Any incubatortechnology transfer entity or scientific founder looking for an entrepreneur to lead their innovative projects is welcome to participate in the matchmaking activity to meet with qualified candidates!
 You will be visible on the partnering platform, to be contacted by potential CEOs.

• If you are a bioentrepreneur looking for a new project to undertake: 
→ Projects looking for a CEO will be visible on the platform and easily identifiable.

Get inspired: 
Having the right team is essential for the development of a biotech project. The Project – CEO matchmaking activity also offers a conference session to get inspired and explore the best ways to find the right talents for a successful project:

Biotech start-up governance:
What makes a good foundation for a company to deliver and grow?

Not registered yet?

Benefit from exclusive discounts with the Early Bird offer,
valid until July 20th, 2023  

Sponsors

Contact

Vincent Tavernier

You are a bioentrepreneur seeking new challenges or you are looking for a passionate CEO to lead your project? Read More »

Pfizer: Gold sponsor of BioFIT 2023

Pfizer: Gold sponsor of BioFIT 2023

We are glad to welcome Pfizer as a Gold sponsor of BioFIT 2023

Many thanks for your support since 2017!

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Join key BioFIT 2023 sponsors such as  Genfit, Pfizer and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

Pfizer: Gold sponsor of BioFIT 2023 Read More »

Share your expertise at BioFIT 2023!

Share your expertise at BioFIT 2023!

Steered by its prestigious committee, the BioFIT conference programme is shaped to correspond to the interests of every player in the sector and to meet the expectations of its stakeholders, whose sharp minds operate in the fast-paced Life Sciences sector. The 2023 programme is rooted in four custom-made tracks, addressing the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.

Look back at the 2022 conferences:

PLENARY SESSION
Biopharma industry has been facing uncertainties in 2023:
What is the impact for early-stage partnering and financing strategies?

The current economic and geopolitical contexts have been difficult for innovation around the world and life sciences are no exception. In a period of inflation, war, high energy prices and financial strains, investments have been shrinking. This session will explore the specific challenges facing the sector and strategies for making the most of the current reality to ensure that biotech innovation continues to be funded and thrive in a complex landscape.

What are the current key issues in the EU biotech ecosystem compared to the US, particularly with regard to drug pricing pressure? What has been the support of public and non-profit organisations to the sector? How has the reduced ability of funds to raise money impacted on the availability of capital in the short to medium term? To what extent does the decline in asset prices impact on the external innovation strategies of pharmaceutical companies? How does balancing the need for innovation with financial viability allow for broader sources of innovation and the structuring of new early-stage collaborations? What is the outlook for life sciences dealmaking in 2024?

 Track 1 – Best practices in R&D collaborations 

Fostering academia-industry partnerships is key to driving innovation in Life Sciences. Which sectors are prone to fuel collaborations? What are the elements to forgather to merge the scientific, academic, advocacy and industry spheres? How are the advances in specific fields influencing academia-pharma partnerships?
 

What are pharma companies’ expectations for pre-competitive research?
• • •
Evolution of collaborative practices in Biotech startups/Academia partnerships
• • •
Best practices for managing risk in early-stage
academia-industry collaborations

Track 2 – Nurturing and licensing early-stage assets

Early-stage assets evolve in an ecosystem where TTOs, scientists and entrepreneurs are closely connected. Understanding the mechanisms and difficulties in nurturing and licensing assets is key to properly influencing the valuation of these assets at an early stage. How can we transform science into business more frequently and efficiently?
 

Adding value to early-stage assets through partnering: What are the working models and how to valorise the partnerships?
• • •
From lab to start-up: Let’s hear about successful spin-out journey
• • •
How are tech transfer offices selecting the projects to back?

Track 3 – From pre-seed to Series A: 
 Accessing early-stage investment 

This track aims to understand the mechanisms enforcing investors’ presence in early stages of development. Are we witnessing surges of investment in specific therapeutic areas? Who are the new players involved in investing in the biotech sector and what are their pre-requisites?
 

From Seed to Series A: What will spark investors’ interest in 2024?
• • •
Exploring the pharma-VC relationship:
How do they build complementary investment strategies?

• • •
What’s new in grant financing across Europe and how to prepare for it?

 Track 4 – Animal Health Highlights 

This track features the latest innovation challenges in animal health R&D and intends to provide a clear understanding of the bridges that can be built between human and animal health. International experts from veterinary research and industry will discuss the latest initiatives to improve and accelerate the development of new diagnostics, vaccines and pharmaceuticals for animal diseases and beyond.
 

Sourcing innovations from a more mature human health market to build assets and start-ups in animal health: How is this happening?
• • •

 Project – CEO matchmaking 

Having the right team is essential for the development of a biotech project or start-up. The Project – CEO matchmaking activity also offers a conference session to get inspired and explore the best ways to find the right talent for a successful project.
 

Biotech start-up governance: What makes a good foundation for a company to deliver and grow?
• • •

Sponsors

Contact

Vincent Tavernier

Share your expertise at BioFIT 2023! Read More »

We are pleased to welcome Boehringer Ingelheim among our 2023 sponsors

We are pleased to welcome Boehringer Ingelheim among our 2023 sponsors

BioFIT event has the honor to count among its sponsors:
Boehringer Ingelheim

Many thanks for your support since 2016!

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Join key BioFIT 2023 sponsors such as  Genfit and Boehringer Ingelheim to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are pleased to welcome Boehringer Ingelheim among our 2023 sponsors Read More »

Join us for the next edition of BioFIT

Join us for the next edition of BioFIT

We hope to have the pleasure to welcome you to the 12th edition of BioFIT
in Marseille, on December 12th and 13th, 2023
and online on December 15th, 2023

With over 1,000 international delegates from 35+ countries (big pharma, emerging and small biotech, diagnostic companies, investors, tech transfer professionals, academia and research institutions), BioFIT is the leading partnering event in Europe for technology transferacademia-industry collaborations and early-stage innovation deals in the field of Life Sciences, as well as the European marketplace for pre-seed, seed and Series A investment rounds in the sector.

Different options to participate in BioFIT:

The partnering activity is the most efficient way to identify and connect with your future project partners, obtain funding and accelerate innovation. BioFIT partnering platform allows to pre-organise one-on-one meetings and optimise the time spent at the event.

Ideally located at the focal point of the event, the exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations and enhance their visibility.

The BioFIT pitch sessions offer the opportunity to detect the most innovative and promising start-ups, R&D projects and licensing opportunities in order to foster partnerships and business development in the Life Sciences and Animal Health fields.

Steered by a prestigious committee, the 2023 conference programme is rooted in four custom-made tracks, addressing the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.

Register before April 13th, 2023 to
benefit from the Super Early Bird offer!

Sponsors

Contact

Vincent Tavernier

Join us for the next edition of BioFIT Read More »

Join BioFIT as an exhibitor

Join BioFIT as an exhibitor

and maximise your outreach to key players in the sector!

1,000+ international delegates will gather in Marseille for 2 days of one-on-one meetings, conferences and pitch sessions in order to build partnerships, source innovative and competitive early-stage R&D projects, facilitate the emergence of collaborative projects, increase licensing opportunities, and obtain funding.
Participants will also get the chance to take advantage of 1 additional day, online, to schedule one-on-one meetings with other attendees.

Position yourself as a key innovative player in Life Sciences and take advantage of an exceptional audience of international delegates by exhibiting at BioFIT.

Take advantage of the Super Early Bird offer before it’s too late,
benefit from a lower rate to book a stand and:

1️⃣​ Enhance your visibility among innovative leaders in the sector gathering at BioFIT
2️⃣​​ Maximise your business opportunities, expand your network and showcase your assets
3️⃣​ Highlight your company thanks to descriptions on our communication tools
4️⃣ Secure your spot: places are limited and assigned on a first-come, first-served basis

Book your stand before April 13th, 2023 to
benefit from the Super Early Bird offer!

You can also register as a delegate with the Super Early Bird offer before April 13th, 2023.

Sponsors

Contact

Vincent Tavernier

Join BioFIT as an exhibitor Read More »

Genfit supports BioFIT this year again

Genfit supports BioFIT this year again

Many thanks to GENFIT for joining BioFIT 2023 as a Silver Sponsor!

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in the research and development of therapeutic and diagnostic solutions in liver diseases, with a rich history and strong scientific heritage spanning more than two decades. Thanks to its expertise in bringing early-stage assets with high potential to late development and pre-commercialization stages, today GENFIT boasts a growing and diversified pipeline of innovative therapeutic and diagnostic solutions.

Join key BioFIT 2023 sponsors such as  Genfit to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

Genfit supports BioFIT this year again Read More »

Have a wonderful new year!

Have a wonderful new year!

The BioFIT Event team wishes you all the best for the coming year
with plenty of meetings, collaborations and innovation

As we kick-off 2023, new challenges lie ahead for innovators in Life Sciences: universities still need to further encourage spin-offs and start-ups to foster entrepreneurial initiatives, new collaborations are required to de-risk and transfer innovative assets and early-stage biotech investment trends are evolving, in focus, geography and volume. There is a lot to look forward to!

By participating in BioFIT, you’ll be able to connect with 1,000+ key international players in the sector to discuss these challenges, exchange with experts and discover innovations to help address these issues.

As the leading partnering event in Europe, BioFIT provides the ideal environment for academic and industrial actors to:
 
  • Build partnerships
  • Source innovative and competitive early-stage R&D projects
  • Facilitate the emergence of collaborative projects
  • Increase licensing opportunities
  • Obtain funding and facilitate market access
🐥 Thanks to the Super Early Bird offer, running until mid-April, you can benefit from very preferential rates to join the BioFIT 2023 edition.
The 12th edition of BioFIT will take place
in Marseille on December 12th and 13th, 2023

Register before April 13th, 2023 to
benefit from the Super Early Bird offer!

Sponsors

Contact

Vincent Tavernier

Have a wonderful new year! Read More »

BioFIT event is very pleased to count IPSEN among its sponsors

BioFIT event is very pleased to count IPSEN among its sponsors

We are pleased to welcome IPSEN as a Bronze sponsor of BioFIT 2022

Ipsen is a public global, mid-sized biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease and Neuroscience. With Specialty Care sales of €2.6bn in FY 2021, Ipsen sells medicines in over 100 countries. Ipsen has 5,000 employees worldwide and innovative research located in leading biotechnological and life-science hubs in France, UK, US and China. For more information, visit ipsen.com and get in touch with our partnering team!

Join key BioFIT 2022 sponsors such as Sartorius, Sanofi, Zoetis, Merck, Boehringer Ingelheim, FINDMED, Genfit, Servier, IPSEN, MSD, Pfizer, Pfizer CentreOne, Roche, ACROBiosystems, AdBio, X’Prochem  and Capital Grand Est to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

BioFIT event is very pleased to count IPSEN among its sponsors Read More »

Ambiom, supporter of BioFIT 2022

Ambiom, supporter of BioFIT 2022

ambiom, a BioFIT supporter, celebrates its 1st anniversary!

 

ambiom s.r.o., (www.ambiom.com) established in 2021, is a life science commercial advisory firm headquartered in Bratislava, Slovakia. ambiom possesses a unique combination of technological, commercial and geographical (CEE) senior-level expertise as well as a vast network of contacts. We assist our clients with their product strategy and

dealmaking, provide feedback and assistance in pricing decisions as well as communication

with authorities and lead the products from the basic science through to their commercialization. 

Over the past year, ambiom has successfully serviced various types of clients and partners, ranging from VC-funded start-ups to life science advisory firms from Slovakia, Switzerland, Sweden and the Netherlands. Our clients value our understanding and facilitation in both scientific and business languages, as well as our pragmatic, open, and hands-on approach. We take pride in guiding our clients through the process of defining and scoping their commercial objectives and taking accountability for implementing the solutions we recommend into action.

 

If you are looking to expand your business to CEE, or simply interested in biotech do get in touch or subscribe to our newsletter!”

Sponsors

Contact

Juliette Vanbastelaere

Ambiom, supporter of BioFIT 2022 Read More »

Scroll to Top
  • No products in the cart.